Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Cardiovascular Outcomes Trial of Anti-Obesity Agent Lorcaserin recommended to continue

pharmaasiaJuly 27, 2017

Tag: cardiovascular , Anti-Obesity Agent

PharmaSources Customer Service